NCT04049123View on ClinicalTrials.gov

A Study of LY900014 in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

October 23, 2020

Study Completion Date

October 23, 2020

Conditions
Healthy
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

Trial Locations (1)

610041

West China Hospital Sichuan University, Chengdu

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04049123 - A Study of LY900014 in Healthy Chinese Participants | Biotech Hunter | Biotech Hunter